Editorial
Copyright ©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Aug 10, 2011; 2(8): 303-310
Published online Aug 10, 2011. doi: 10.5306/wjco.v2.i8.303
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Circulating tumor cell and metastatic process. EMT: Epithelial-mesenchymal transition; CTC: Circulating tumor cell; DTC: Disseminated tumor cell; MET: Mesenchymal-epithelial transition.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Identification of tumor cells and white blood cells using monoclonal antibodies. EpCAM: Epithelial-cell adhesion molecule; DAPI: 4’,6-diamidino-2-phenylindole.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Measurement of circulating tumor cells by the CellSearch® System. CTC: Circulating tumor cell; DAPI: 4’,6-diamidino-2-phenylindole; CK: Cytokeratins; PE: Phycoerythrin.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Kaplan-Meier estimates of probabilities of progression-free survival in patients with metastatic breast cancer who had less than 5 circulating tumor cells and those who had 5 or more circulating tumor cells (before initiation of a new line of therapy)[29]. CTC: Circulating tumor cell.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Kaplan-Meier estimates of probabilities of overall survival in patients with metastatic breast cancer who had less than 5 circulating tumor cells and those who had 5 or more circulating tumor cells (before initiation of a new line of therapy)[29]. CTC: Circulating tumor cell.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Kaplan-Meier estimates of probabilities of progression-free survival in patients with metastatic breast cancer who had less than 5 circulating tumor cells and those who had 5 or more circulating tumor cells (at the first follow-up visit after initiation of a new line of therapy)[29]. CTC: Circulating tumor cell.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 Kaplan-Meier estimates of probabilities of overall survival in patients with metastatic breast cancer who had less than 5 circulating tumor cells and those who had 5 or more circulating tumor cells (at the first follow-up visit after initiation of a new line of therapy)[29]. CTC: Circulating tumor cell.
Figure 8
Open in New Tab Full Size Figure Download Figure
Figure 8 Study design of the Southwest Oncology Group Trial S0500. CTC: Circulating tumor cell.
Figure 9
Open in New Tab Full Size Figure Download Figure
Figure 9 Circulating tumor cell values at 8:00 AM and at 8:00 PM in the 51 assessable patients[36]. CTC: Circulating tumor cell.